Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases
Minimally Invasive(Laparoscopic and Robotic) Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases
1 other identifier
interventional
220
1 country
1
Brief Summary
To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2017
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedMarch 29, 2019
March 1, 2019
2.1 years
June 28, 2017
March 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
disease-free survival (DFS)
DFS was calculated from the date of liver resection to the date of death or recurrence or new tumors developing
3 years disease-free survival
Secondary Outcomes (2)
Overall survival (OS)
5 years overall survival
Sugical complications
1 months after sugery
Study Arms (2)
Minimally Invasive surgery
EXPERIMENTALthe intevention of Minimally Invasive procedure contains laparoscopic and robotic liver resection
Open surgery
OTHERthe open surgery means traditional open surgery for liver resection
Interventions
laparoscopic and robotic procedure for liver resection
Eligibility Criteria
You may qualify if:
- patients were diagnosed with colorectal cancer liver metastases
- without extra-hepatic liver metastases
- age were within 18-75 yeas
- the numbers of metastases more than 3
- the maximal tumor size of liver metastases more than 10 cm
You may not qualify if:
- liver metastases were unresectable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xu jianminlead
Study Sites (1)
Wenju Chang
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The assessor was masking for patients treatment arms
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of colorectal cancer center
Study Record Dates
First Submitted
June 28, 2017
First Posted
March 29, 2019
Study Start
March 1, 2019
Primary Completion
April 1, 2021
Study Completion
April 1, 2024
Last Updated
March 29, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share